WMS Partners’s Pfizer PFE Stock Holding History

WMS Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-49,397	Closed	-$1.31M	–	198
2024 Q4	$1.31M	Sell	49,397 -1,211	-2%	-$32.8K	0.07%	106
2024 Q3	$1.46M	Buy	50,608 +3,449	+7%	+$101K	0.08%	97
2024 Q2	$1.32M	Sell	47,159 -1,087	-2%	-$29.9K	0.08%	87
2024 Q1	$1.34M	Buy	48,246 +422	+0.9%	+$11.7K	0.09%	93
2023 Q4	$1.38M	Sell	47,824 -5,394	-10%	-$163K	0.1%	83
2023 Q3	$1.77M	Sell	53,218 -857	-2%	-$30.3K	0.14%	64
2023 Q2	$1.98M	Sell	54,075 -459	-0.8%	-$17.9K	0.16%	58
2023 Q1	$2.22M	Buy	54,534 +1,127	+2%	+$48.7K	0.19%	56
2022 Q4	$2.74M	Sell	53,407 -8,653	-14%	-$415K	0.27%	51
2022 Q3	$2.72M	Sell	62,060 -1,447	-2%	-$70.3K	0.37%	43
2022 Q2	$3.33M	Buy	63,507 +948	+2%	+$48.3K	0.52%	37
2022 Q1	$3.24M	Buy	62,559 +4,740	+8%	+$246K	0.44%	34
2021 Q4	$3.41M	Sell	57,819 -736	-1%	-$36.5K	0.73%	27
2021 Q3	$2.52M	Buy	58,555 +9	+0%	+$399	0.37%	41
2021 Q2	$2.29M	Sell	58,546 -1,218	-2%	-$47.4K	0.34%	42
2021 Q1	$2.17M	Buy	59,764 +1,693	+3%	+$60.1K	0.49%	38
2020 Q4	$2.14M	Sell	58,071 -6,635	-10%	-$243K	0.37%	40
2020 Q3	$2.25M	Buy	64,706 +67	+0.1%	+$2.35K	0.44%	35
2020 Q2	$2M	Sell	64,639 -345	-0.5%	-$11.7K	0.42%	40
2020 Q1	$2.01M	Sell	64,984 -4,589	-7%	-$156K	0.56%	36
2019 Q4	$2.59M	Sell	69,573 -6,773	-9%	-$241K	0.58%	38
2019 Q3	$2.6M	Sell	76,346 -221	-0.3%	-$8.04K	0.63%	35
2019 Q2	$3.15M	Buy	76,567 +7,300	+11%	+$290K	0.77%	30
2019 Q1	$2.79M	Sell	69,267 -136	-0.2%	-$5.45K	0.7%	30
2018 Q4	$2.87M	Buy	69,403 +10,041	+17%	+$417K	0.8%	28
2018 Q3	$2.48M	Sell	59,362 -1,607	-3%	-$61.9K	0.28%	54
2018 Q2	$2.1M	Sell	60,969 -2,149	-3%	-$73.4K	0.24%	59
2018 Q1	$2.13M	Sell	63,118 -374	-0.6%	-$12.9K	0.25%	61
2017 Q4	$2.18M	Buy	63,492 +999	+2%	+$34.1K	0.25%	60
2017 Q3	$2.12M	Buy	62,493 +454	+0.7%	+$14.6K	0.25%	62
2017 Q2	$1.98M	Buy	62,039 +1,941	+3%	+$61.2K	0.24%	63
2017 Q1	$1.95M	Buy	60,098 +106	+0.2%	+$3.34K	0.25%	61
2016 Q4	$1.85M	Buy	59,992 +891	+2%	+$27.2K	0.25%	62
2016 Q3	$1.9M	Buy	59,101 +2,461	+4%	+$82.3K	0.25%	60
2016 Q2	$1.89M	Sell	56,640 -685	-1%	-$21.9K	0.26%	61
2016 Q1	$1.61M	Sell	57,325 -368	-0.6%	-$10.5K	0.22%	69
2015 Q4	$1.77M	Buy	57,693 +466	+0.8%	+$14.7K	0.25%	65
2015 Q3	$1.71M	Sell	57,227 -55,353	-49%	-$1.77M	0.26%	65
2015 Q2	$3.58M	Buy	112,580 +1,987	+2%	+$64.8K	0.42%	52
2015 Q1	$3.65M	Buy	110,593 +49,767	+82%	+$1.58M	0.45%	49
2014 Q4	$1.8M	Buy	60,826 +2,759	+5%	+$79.1K	0.28%	64
2014 Q3	$1.63M	Sell	58,067 -776	-1%	-$21.8K	0.25%	64
2014 Q2	$1.66M	Sell	58,843 -211	-0.4%	-$6.01K	0.26%	64
2014 Q1	$1.8M	Buy	59,054 +145	+0.2%	+$4.32K	0.29%	62
2013 Q4	$1.71M	Buy	58,909 +1,287	+2%	+$37.5K	0.28%	62
2013 Q3	$1.57M	Sell	57,622 -3,730	-6%	-$101K	0.3%	59
2013 Q2	$1.63M	Buy	+61,352	New	+$1.7M	0.3%	62

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WMS Partners's PFE Position: Q1 2025 in Review

WMS Partners sold out of Pfizer (PFE) in Q1 2025, closing a stake of 49,397 shares — an estimated $1.31M sold.

WMS Partners first reported a position in PFE in Q2 2013 and held it in 47 quarters. The position peaked at $3.65M in Q1 2015. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

WMS Partners reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
WMS Partners sold 49,397 Pfizer shares in Q1 2025, an estimated $1.31M.
WMS Partners first reported a position in Pfizer in Q2 2013 and held it in 47 quarters.
WMS Partners's Pfizer position peaked at $3.65M in Q1 2015.
2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on WMS Partners's 13F filing for Q1 2025.